NEW YORK (GenomeWeb News) – Menlo Park, Calif.-based Pacific Biosciences today said that it recently received $20 million in funding from new investor Blackstone Cleantech Venture Partners.
With the new funds, Pac Bio has raised $120 million in its latest financing round. It plans to use the resources to support its efforts to bring its Single-Molecule, Real-Time DNA sequencing platform to the market by the second half of 2010. The company said it has raised $193 million since it was founded in 2004.